Lv4
516 积分 2024-06-25 加入
[Consensus on the molecular residual disease testing in solid tumor]
1个月前
已完结
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
2个月前
已完结
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
2个月前
已完结
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC
2个月前
已完结
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
2个月前
已完结
中药龙骨真伪鉴别方法研究
2个月前
已完结
龙骨的质量评价研究
2个月前
已完结
[Chinese expert consensus on the diagnosis and treatment of advanced RET fusion-positive non-small cell lung cancer (2023 edition)]
3个月前
已完结
[Clinical practice guideline on anaplastic lymphoma kinase-tyrosine kinase inhibitors for non-small cell lung cancer (2025 edition)]
3个月前
已完结
Phase 2 study of amivantamab plus lazertinib in previously-treated patients withEGFR mutant lung cancers with brain and leptomeningeal metastases
5个月前
已完结
皖公网安备34019202002308
